JAMA Clinical Reviews podcast

Treatment of Complicated Staphylococcus aureus Bacteremia

0:00
11:35
Rewind 15 seconds
Fast Forward 15 seconds

Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS randomized clinical trial and more with JAMA Deputy Editor Preeti Malani, MD, MSJ.

Related Content:

-----------------------------------

JAMA Editors' Summary

More episodes from "JAMA Clinical Reviews"